Skip to main content
. 2019 May 2;4(9):e122627. doi: 10.1172/jci.insight.122627

Figure 2. Kinetics of ex vivo T cell expansion.

Figure 2

Cumulative fold T cell expansion ex vivo is depicted for patients with CLL on ibrutinib (IBR) at the time of leukapheresis (blue lines) versus IBR-naive patients (red lines) versus patients previously on ibrutinib (green line). Note log scale.